A novel gene delivery system targeting cells expressing VEGF receptors

Cell Research

Volumn 9, Issue 1, 1999, Pages 11-25

  Li, Jun Min ^a,c   Han, Jun Song ^a   Huang, Yi ^a   Tian, Pei Kun ^a   Qu, Shu Min ^a   Yao, Min ^a   Jiang, Hui Qiu ^a   Wan, Da Fang ^a   Luo, Jing Chu ^b   Gu, Cheng Xiao ^b   Gu, Jian Ren ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

^b PEKING UNIVERSITY   (China)

^c Zhejiang Taizhou Normal College   (China)

Author keywords

Gene delivery system; Targeting; Tumor; Vascular endothelial cells; VEGF receptors

Indexed keywords

BOVINAE; MUS MUSCULUS;

BETA GALACTOSIDASE; GROWTH FACTOR RECEPTOR; HEPARIN; PEPTIDE; PROTAMINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING COMPETITION; CATTLE; CELL CULTURE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETICS; HUMAN; MOLECULAR GENETICS; MOUSE; NUDE MOUSE; REPORTER GENE; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; BETA-GALACTOSIDASE; BINDING, COMPETITIVE; CATTLE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HEPARIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTAMINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0033090418     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290002     Document Type: Article

References (18)

1. George Y Wu, Catherine H Wu. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987; 262(10):4429-32.
2. Ernst Wagner, Martin Zenke, Matt Cotton et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990; 87:3410-4.
3. Tian Peikun, Ren Shengjun, Ren Changchun et al. A Novel Receptor-targeted Gene Delivery System for cancer gene therapy, Science in China (Series C), accepted.
4. Ulla Wienhues, Keiichi Hosokawa. Arnd Hoveler et al. A novel method for transfection and expression of reconstituted DNA-protein complexes in eukaryotic cells, DNA. 1987; 6(1):81-9.
5. Judah Folkman, Yuen Shing. Angiogenesis. J Biol Chem 1992; 267(16):10931-34.
6. Napoleone Ferrara. Vascular endothelial growth factor. Trends Cardiovasc Med 1993; 3:244-50.
7. Erika Hatva, Arta Kaipainen, Panu Mentula et al. Expression of endothelial cell specific receptor tyrosine kinases and growth factors in human brain tumors, American Journal of Pathology. 1995; 146(2):368-78.
8. Kunio Suzuki, Norio Hayashi, Yasuhide Miyamoto et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma, Cancer Res 1996; 56:3004-9.
9. Christine A Boocock, D Stepjen Charnock-Jones, Andrew M Sharkey et al. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J Nat Cancer Inst 1995; 87:506-16.
10. Bo Liu, Helena M Earl, Dilair Baban et al. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophy Res Commun 1995; 217(3):721-7.
11. Adrian L Harris, Huatang zhang, Amir Moghaddam et al. Breast cancer angiogenesis-new approaches to therapy via antigiogenesis, hypoxic activated drugs and vascular targeting, Breast Cancer Reasearch and Treament. 1996; 38:97-108.
12. Karl H Plate, Georg Breier, Herbert A Weich et al. Vascular endothelial growth factor is a potential tumour andiogenesis factor in human gliomas in vivo Nature, 1992; 359:845-8.
13. Mingli Sheng et al. Culture of Vascular Endothelial cell 1987; 14(1):71-3.
14. S. Ramakrishnan, TA Olson, VL Bautch et al. Vascular endothelial growth factor-toxin conjuate specifically inhibits KDR/flk-1 positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 1996; 56:1324-30.
15. Hela Gitary-Goren, Shay Soker, Israel Vlodavsky et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface asssociated heparin-like molecules. J Biol Chem 1992; 267(9):6093-8.
16. G Neufeld, D Gospodarowicz. Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J Cell Phys 1987; 132:287-94
17. Masayuki Murata, Satoshi Kagiwada, Sho Takahashi et al. Membrane Fusion induced by mutual interaction of the two charge-reversed amphiphilic peptides at neutral pH. J Biol Chem 1991; 266(22):14353-8.
18. Judah Folkman. What is the evidence that tumors are angiogenesis dependent? J Nat Cancer Inst 1990; 88:4-6.